Peripheral Arterial Disease, Risk Factors and TAVR

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Peripheral Arterial Disease

Risk Factors

TAVR

Alternative access in transcatheter aortic valve replacement—an updated focused review

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

However, with the compelling evidence on the safety and efficacy of transcatheter aortic valve replacement (TAVR), it has become the gold standard treatment option for many patients with symptomatic severe AS. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable.

Aortic valve

Aortic valve Aortic TAVR Peripheral Arterial Disease

Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

With this longer lifespan, calcific aortic stenosis (AS) was identified as an emerging critical risk factor for cardiac death in older patients. However, HGPS patient-device size mismatch, pervasive peripheral arterial disease, skin and bone abnormalities, and lifelong failure to thrive present unique challenges to intervention.

Stenosis

Stenosis Aortic Peripheral Arterial Disease TAVR

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Cardiovascular Update

Alternative access in transcatheter aortic valve replacement—an updated focused review

Intervention for critical aortic stenosis in Hutchinson-Gilford progeria syndrome

Webinars

Stay Connected